Read-onlySigned in as demo@nsight.app
As of 10 Oct 2026 · demonstration dates
Portfolio reports show the current active book. Closed and archived borrowers, including their history, are available in All Borrowers.
Kilnbrace Specialty Products
Valuation support — Q2 2026
Marks received: 1/1 credit positions; 1/1 equity positions. Totals include known marks only. LTM analysis requires four consecutive financial quarters.
$6.1M
Credit FV · Q2 2026
$0.0M
vs Q1 2026
0.47x
Credit FV / LTM EBITDA
$13.0M
LTM EBITDA (unadjusted)
Tight
Binding Covenant
Mark against Credit
Credit fair value ($M)$6.1M latest
6.06.06.16.1
Interest Coverage cushion (%)
———8.4
Total Leverage cushion (%)
———9.5
Q3 2025Q4 2025Q1 2026Q2 2026
Method and Assumptions
| Quarter | Credit FV | Method | Note |
|---|---|---|---|
| Q3 2025 | $6.0M | Not documented | — |
| Q4 2025 | $6.0M | Not documented | — |
| Q1 2026 | $6.1M | Not documented | — |
| Q2 2026 | $6.1M | Cost | Held at cost less minor accrual — UNCHANGED FOR 3 QUARTERS |
Valuation Events
| Quarter | Event | Note | Recorded by |
|---|---|---|---|
| Q2 2026 | Auditor inquiry | Auditor questioned unchanged mark against declining EBITDA | portfolio.analyst@nsns-fund.example |